Abstract
Studies of the multifunctional protein p11 (also known as S100A10) are shedding light on the molecular and cellular mechanisms underlying depression. Here, we review data implicating p11 in both the amplification of serotonergic signalling and the regulation of gene transcription. We summarize studies demonstrating that levels of p11 are regulated in depression and by antidepressant regimens and, conversely, that p11 regulates depression-like behaviours and/or responses to antidepressants. Current and future studies of p11 may provide a molecular and cellular framework for the development of novel antidepressant therapies.
| Original language | English |
|---|---|
| Pages (from-to) | 673-680 |
| Number of pages | 8 |
| Journal | Nature Reviews Neuroscience |
| Volume | 14 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 2013 |
Bibliographical note
Funding Information:We acknowledge the important contributions of N. Heintz, E. Schmidt, D. Patel, P. Gao and M. Kaplitt to our understanding of the various functions of p11. This work was supported by the Fisher Center for Alzheimer’s Research Foundation (P.S. and P.G.), W81XWH‑09‑1‑0402 (P.G.), NIH MH090963 (P.G.), NIDA1RC2DA028968 (P.G.), The JPB Foundation (P.G.), W81XWH‑09‑1‑0392 (Y.K.), W81XWH‑09‑1‑0401 (J.L.W.‑S.), and Swedish Research Council (P.S.). We apologize to the authors of the many inter‑ esting studies that could not be included owing to space constraints.
Fingerprint
Dive into the research topics of 'P11 and its role in depression and therapeutic responses to antidepressants'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver